Millenium Biologix Inc.
Records under this name other than patents Millenium Biologix Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Millenium Biologix Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,499,780 | Advanced tissue engineering system Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,498,043 | Silicon Substituted Oxyapatite Formerly held Term ended Term ended Jun 24, 2026 · High confidence | Term ended | Term ended Jun 24, 2026 | High confidence |
| US 8,546,142 | Reverse flow perfusion of three-dimensional scaffolds Formerly held Lapsed on the fee record Ended Oct 1, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 1, 2025 | From the USPTO record |
| US 9,133,236 | Connective Tissue Stimulating Peptides Formerly held Term ended Term ended Sep 5, 2025 · High confidence | Term ended | Term ended Sep 5, 2025 | High confidence |
| US 8,492,140 | Automated tissue engineering system Formerly held Term ended Term ended Jun 7, 2025 · From the USPTO record | Term ended | Term ended Jun 7, 2025 | From the USPTO record |
| US 9,534,195 | Automated tissue engineering system Term ended Term ended Aug 5, 2024 · From the USPTO record | Term ended | Term ended Aug 5, 2024 | From the USPTO record |
| US 10,723,986 | Automated tissue engineering system Term ended Term ended May 30, 2024 · From the USPTO record | Term ended | Term ended May 30, 2024 | From the USPTO record |
| US 7,875,342 | Porous Ceramic Composite Bone Grafts Formerly held Term ended Term ended Oct 28, 2023 · High confidence | Term ended | Term ended Oct 28, 2023 | High confidence |
| US 7,491,691 | Connective Tissue Stimulating Peptides Formerly held Term ended Term ended May 2, 2023 · High confidence | Term ended | Term ended May 2, 2023 | High confidence |
| US 11,384,117 | Connective Tissue Stimulating Peptides Formerly held Term ended Term ended May 2, 2023 · High confidence | Term ended | Term ended May 2, 2023 | High confidence |